Skip to Main Content

Paper Details

Biomarkers in chronic graft-versus-host disease: quo vadis?
Bone Marrow Transplant
48
2018
CD163, CD19, CD19+CD21low B cells, CD21low, CD4+, CD4+ T-cell subsets, CXCL10, CXCL11, CXCL9, GvHD, NK, NK cell subsets, ST2, acute GvHD, cGvHD, chronic GvHD, chronic graft-versus-host disease, graft-versus-host disease, matrix metalloproteinase-3, osteopontin, patient
Author NameAffiliation
Sophie PaczesnyIndiana University School of Medicine
Sophie PaczesnyIndiana University School of Medicine
Steven Z PavleticNational Cancer Institute
Steven Z PavleticNational Cancer Institute
Frances T HakimNational Cancer Institute
Frances T HakimNational Cancer Institute
Anne M DickinsonInstitute of Cellular Medicine, Newcastle University
Anne M DickinsonInstitute of Cellular Medicine, Newcastle University
Matthias EdingerUniversity Hospital of Regensburg
  • 1 - 9

Datasets

Release 1.2